Equity Overview
Price & Market Data
Price: $0.208
Daily Change: -$0.0754 / 36.22%
Range: $0.201 - $0.284
Market Cap: $684,474
Volume: 5,490
Performance Metrics
1 Week: 0.30%
1 Month: -16.37%
3 Months: -79.31%
6 Months: -89.32%
1 Year: -94.04%
YTD: -89.97%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.